Cape Town - 2026 ISMRM-ISMRT Annual Meeting and Exhibition
9 May 2026 – 14 May 2026 · Cape Town, South Africa
565-04-008 ISMRM Abstract

Radiomics-Based Assessment of Overall Survival in Olfactory Neuroblastoma

Primary: Neuro - Head & Neck/ENT
Secondary: Analysis Methods - Classification and Prediction
565-04-008 · Neuroradiomics · Wednesday, 13 May, 2:35 PM–3:30 PM · Digital Posters Row F
Keywords: Diagnosis/Prediction Radiomics Olfactory Neuroblastoma Overall survival
Accepted
yongchao wu 1, Xiwen Wang1, Shanbin Sun1, Tao Liu2, Dandan Zheng2, Zhaohui Liu1
1Beijing Tongren Hospital, Capital Medical University, Beijing, China
2Clinical and Technical Support, Philips Healthcare (Beijing), Beijing, China
Presenting Author: yongchao wu

Synopsis

Motivation:
Goals:
Approach:
Results:
Full abstract & presentation

The full text, figures, and any recorded presentation for this abstract are not shown here. Log in if you are a member or registered attendee with access.

Full abstracts, figures, and presentations for Cape Town - 2026 ISMRM-ISMRT Annual Meeting and Exhibition are available to registered attendees. This content becomes freely available to the public roughly two years after the meeting.

To request or purchase access, contact the ISMRM Central Office at info@ismrm.org.

Log in

References

1. Bell D, Hanna EY, Weber RS, et al. Neuroendocrine neoplasms of the sinonasal region. Head Neck. 2016;38 Suppl 1:E2259-E2266. doi:10.1002/hed.24152 [doi]
2. Tajudeen BA, Arshi A, Suh JD, St John M, Wang MB. Importance of tumor grade in esthesioneuroblastoma survival: a population-based analysis. JAMA Otolaryngol Head Neck Surg. 2014;140(12):1124-1129.doi:10.1001/jamaoto.2014.2541 [doi]
3. Jethanamest D, Morris LG, Sikora AG, Kutler DI. Esthesioneuroblastoma: a population-based analysis of survival and prognostic factors. Arch Otolaryngol Head Neck Surg. 2007;133(3):276-280. doi:10.1001/archotol.133.3.276 [doi]
4. Bell D, Saade R, Roberts D, et al. Prognostic utility of Hyams histological grading and Kadish-Morita staging systems for esthesioneuroblastoma outcomes. Head Neck Pathol. 2015;9(1):51-59. doi:10.1007/s12105-014-0547-3 [doi]
5. Lopez F, Agaimy A, Franchi A, et al. Update on olfactory neuroblastoma. Virchows Arch. 2024;484(4):567-585. doi:10.1007/s00428-024-03758-z [doi]
6. Ni G, Pinheiro-Neto CD, Iyoha E, et al. Recurrent Esthesioneuroblastoma: Long-Term Outcomes of Salvage Therapy. Cancers (Basel). 2023;15(5):1506. Published 2023 Feb 28. doi:10.3390/cancers15051506 [doi]

Cite this abstract

http://echo.ismrm.org/p/ISMRM2026/565-04-008